CUREVAC ACQUISITION BY BIONTECH
GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...
- Load More
125 passengers and crew hit with highly contagious stomach virus on cruise from San Francisco
Last-minute launch problem delays satellite rescue mission for NASA
'Just about everything we need': Trump claims Iran has accepted nearly all US conditions
Avenue Supermarts shares in focus after Q1 update; revenue rises 15.1% to Rs 18,343 crore
Meta's Mark Zuckerberg says AI agent tech progressing slower than expected
Ayatollah Khamenei's coffin taken to the site of assassination: Iranian media
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service